Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05394662 · ClinicalTrials.gov registry record · Phase 3
Safety and Effectiveness of Juveena™ Hydrogel System Following Transcervical Gynecologic Procedures (TCGP) At High-Risk for Intrauterine Adhesions
A Phase 3 study, sponsored by Rejoni.
- Completed
- Registry status
- Phase 3
- Development phase
- 150
- Enrollment target
NCT05394662 is a Phase 3 study that has completed, run by Rejoni. The registered enrollment target is 150 participants.
The verdict
NCT05394662, a Phase 3 study, has completed, sponsored by Rejoni.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 150 participants
- Enrollment target
Study Summary
This study is to determine whether intrauterine instillation of Juveena hydrogel following adhesiogenic hysteroscopic procedures (TCGP + Juveena) can safely and effectively reduce the incidence and severity of intrauterine adhesions (IUA) compared to TCGP alone.
Interventions
- DEVICE Juveena Hydrogel System
- PROCEDURE Transcervical Gynecologic Procedures (TCGP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2022-08-11 |
| Est. Completion | 2025-04-23 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05394662
The ClinicalTrials.gov registry entry for NCT05394662 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rejoni, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Juveena Hydrogel System is the first listed.
NCT05394662 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05394662 about?
NCT05394662 is a clinical study titled "Safety and Effectiveness of Juveena™ Hydrogel System Following Transcervical Gynecologic Procedures (TCGP) At High-Risk for Intrauterine Adhesions". This study is to determine whether intrauterine instillation of Juveena hydrogel following adhesiogenic hysteroscopic procedures (TCGP + Juveena) can safely and effectively reduce the incidence and severity of intrauterine adhesions (IUA) compared to TCGP alone.
What is the current status of trial NCT05394662?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 150 participants. The study started on 2022-08-11. Estimated completion is 2025-04-23.
What interventions are being tested in trial NCT05394662?
The interventions under investigation include: Juveena Hydrogel System (DEVICE), Transcervical Gynecologic Procedures (TCGP) (PROCEDURE).
Who is sponsoring clinical trial NCT05394662?
This trial is sponsored by Rejoni, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.